Protara Therapeutics Stock Price on November 20, 2024
| TARA Stock | USD 3.04 0.10 3.40% |
Below is the normalized historical share price chart for Protara Therapeutics extending back to October 22, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Protara Therapeutics stands at 3.04, as last reported on the 28th of November, with the highest price reaching 3.16 and the lowest price hitting 2.89 during the day.
If you're considering investing in Protara Stock, it is important to understand the factors that can impact its price. Protara Therapeutics appears to be slightly risky, given 3 months investment horizon. Protara Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.17, which implies the firm had a 0.17% return per unit of risk over the last 3 months. By analyzing Protara Therapeutics' technical indicators, you can evaluate if the expected return of 0.76% is justified by implied risk. Please evaluate Protara Therapeutics' Risk Adjusted Performance of 0.1147, coefficient of variation of 717.84, and Semi Deviation of 2.77 to confirm if our risk estimates are consistent with your expectations.
At present, Protara Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 12.9 K, whereas Other Stockholder Equity is forecasted to decline to about 237.6 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price To Sales Ratio is forecasted to decline to 8.65. Protara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of October 2014 | 200 Day MA 2.6632 | 50 Day MA 2.111 | Beta 1.786 |
Protara |
Sharpe Ratio = 0.1734
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TARA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.37 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.76 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Protara Therapeutics is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protara Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.7415 | Book Value 6.012 | Enterprise Value -16.1 M | Enterprise Value Ebitda 0.7403 | Shares Float 15.2 M |
Related Headline
TRACON Pharmaceuticals Headline on 28th of June 2024
TRACON Pharmaceuticals Downgraded to Hold at StockNews.com -... by news.google.com
TRACON Pharmaceuticals Downgraded to Hold at StockNews.com Defense World
Protara Therapeutics Valuation on November 20, 2024
It is possible to determine the worth of Protara Therapeutics on a given historical date. On November 20, 2024 Protara was worth 2.3 at the beginning of the trading date compared to the closed value of 2.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Protara Therapeutics stock. Still, in general, we apply an absolute valuation method to find Protara Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Protara Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Protara Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.30 | 2.34 | 2.21 | 2.32 | 121,035 | |
11/20/2024 | 2.30 | 2.34 | 2.28 | 2.31 | 26,903 |
| 2.34 | 2.40 | 2.28 | 2.29 | 64,860 |
| Backtest Protara Therapeutics | | | Protara Therapeutics History | | | Protara Therapeutics Valuation | Previous | Next |
Protara Therapeutics Trading Date Momentum on November 20, 2024
| On November 21 2024 Protara Therapeutics was traded for 2.29 at the closing time. The top price for the day was 2.40 and the lowest listed price was 2.28 . The trading volume for the day was 64.9 K. The trading history from November 21, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.87% . The trading delta at closing time against the current closing price is 29.87% . |
Protara Therapeutics Fundamentals Correlations and Trends
By evaluating Protara Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Protara Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Protara financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Protara Therapeutics Stock history
Protara Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Protara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Protara Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Protara Therapeutics stock prices may prove useful in developing a viable investing in Protara Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 11.3 M | 11.9 M | |
| Net Loss | -59.4 M | -56.4 M |
Protara Therapeutics Quarterly Net Working Capital |
|
Protara Therapeutics Stock Technical Analysis
Protara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Protara Therapeutics Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Protara Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Protara Therapeutics November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Protara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Protara Therapeutics shares will generate the highest return on investment. By undertsting and applying Protara Therapeutics stock market strength indicators, traders can identify Protara Therapeutics entry and exit signals to maximize returns
Protara Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Protara Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Protara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Protara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1147 | |||
| Jensen Alpha | 0.5617 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.1458 | |||
| Treynor Ratio | 2.51 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Protara Stock analysis
When running Protara Therapeutics' price analysis, check to measure Protara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protara Therapeutics is operating at the current time. Most of Protara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protara Therapeutics' price. Additionally, you may evaluate how the addition of Protara Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |